Researchers have utilized LAMP technology to develop a new rapid and sensitive low-cost test for Zika virus; they hope it will allow more effective tracking of disease spread.
New research has investigated the burden of nontuberculosis mycobacterium pulmonary disease in Germany, discovering high mortality and financial burden.
A novel type of wound dressing that combines both hydrogel dressings and chitosan could reduce the risk of bacterial infection in recovering patients.
A novel, bioinspired antimicrobial treatment, consisting of iodo-thiocyanate complexes, has demonstrated promising results as a bactericidal compound, according to new research.
CRISPR/Cas9 has been demonstrated to excise HIV-1 DNA from host tissues in vivo according to new research; this marks a major step towards a permanent cure for HIV infection.
Researchers have utilized CRISPR/Cas9 technology on human induced pluripotent stem cells to identify genes involved in fighting off Chlamydia trachomatis infections.
Host gene expression patterns could be utilized to accurately diagnose malaria according to research presented at ECCMID 2017 on World Malaria Day.
New research suggests it may be possible to quickly and accurately diagnose drug-resistant bacteria utilizing equipment already owned by hospitals.
Research presented at ECCMID 2017 highlighted the potential of intracellular bacterium Wolbachia to control and prevent arboviruses, including Zika and chikungunya.